These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 17405767)

  • 1. A clinical rating scale for progressive supranuclear palsy.
    Golbe LI; Ohman-Strickland PA
    Brain; 2007 Jun; 130(Pt 6):1552-65. PubMed ID: 17405767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and dual-tasking aspects in frequent and infrequent fallers with progressive supranuclear palsy.
    Lindemann U; Nicolai S; Beische D; Becker C; Srulijes K; Dietzel E; Bauer S; Berg D; Maetzler W
    Mov Disord; 2010 Jun; 25(8):1040-6. PubMed ID: 20131396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical and epidemiological description of a series of patients diagnosed as suffering from progressive supranuclear palsy].
    Alvarez-González E; Maragoto-Rizo C; Arteche-Prior M; Pérez-Parra S; Carballo M; Alvarez-González L
    Rev Neurol; 2004 Dec 1-15; 39(11):1006-10. PubMed ID: 15597260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive supranuclear palsy: a clinical, natural history and disability study].
    Macia F; Ballan G; Yekhlef F; Delmer O; Vital C; Lagueny A; Tison F
    Rev Neurol (Paris); 2003 Jan; 159(1):31-42. PubMed ID: 12618651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Descriptive study of a serie of patients affected by progressive supranuclear palsy].
    Villanueva-Haba VE; Garcés M; de Vera A; Valero C; Burguera JA
    Rev Neurol; 2001 Jun 1-15; 32(11):1027-30. PubMed ID: 11562823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases.
    Birdi S; Rajput AH; Fenton M; Donat JR; Rozdilsky B; Robinson C; Macaulay R; George D
    Mov Disord; 2002 Nov; 17(6):1255-64. PubMed ID: 12465065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy.
    Abate F; Russo M; Ricciardi C; Tepedino MF; Romano M; Erro R; Pellecchia MT; Amboni M; Barone P; Picillo M
    Parkinsonism Relat Disord; 2023 Apr; 109():105345. PubMed ID: 36868037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of decline in progressive supranuclear palsy.
    Litvan I; Kong M
    Mov Disord; 2014 Apr; 29(4):463-8. PubMed ID: 24615741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy: phenotypic sex differences in a clinical cohort.
    Baba Y; Putzke JD; Whaley NR; Wszolek ZK; Uitti RJ
    Mov Disord; 2006 May; 21(5):689-92. PubMed ID: 16342256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
    García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP
    Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging measures predict progression in progressive supranuclear palsy.
    Whitwell JL; Xu J; Mandrekar J; Gunter JL; Jack CR; Josephs KA
    Mov Disord; 2012 Dec; 27(14):1801-4. PubMed ID: 22415715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
    Brittain C; McCarthy A; Irizarry MC; McDermott D; Biglan K; Höglinger GU; Lorenzl S; Del Ser T; Boxer AL; ; ; ;
    Parkinsonism Relat Disord; 2019 Mar; 60():138-145. PubMed ID: 30201421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.
    Hewer S; Varley S; Boxer AL; Paul E; Williams DR;
    Mov Disord; 2016 Oct; 31(10):1574-1577. PubMed ID: 27324431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal-proximal differences in limb apraxia in corticobasal degeneration but not progressive supranuclear palsy.
    Soliveri P; Piacentini S; Paridi D; Testa D; Carella F; Girotti F
    Neurol Sci; 2003 Oct; 24(3):213-4. PubMed ID: 14598093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration.
    Steffen TM; Boeve BF; Mollinger-Riemann LA; Petersen CM
    Phys Ther; 2007 Aug; 87(8):1078-87. PubMed ID: 17578939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.
    Bang J; Lobach IV; Lang AE; Grossman M; Knopman DS; Miller BL; Schneider LS; Doody RS; Lees A; Gold M; Morimoto BH; Boxer AL;
    Parkinsonism Relat Disord; 2016 Jul; 28():41-48. PubMed ID: 27172829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.
    Matsumoto H; Ohminami S; Goto J; Tsuji S
    Arch Neurol; 2008 Jun; 65(6):827-9. PubMed ID: 18541806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis of patients with progressive supranuclear palsy].
    Aiba I; Saito Y; Tamakoshi A; Matsuoka Y
    Rinsho Shinkeigaku; 2005 Aug; 45(8):565-70. PubMed ID: 16180703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.